Company Monitoring Page for Sanofi

latest headlines for company on cafepharma

Sanofi says reaches patent deal with Eli Lilly on Lantus SoloSTAR
Yahoo/Reuters
Mon, 09/28/15 - 10:13 am
Tags:
Sanofi, Eli Lilly, patents, diabetes, Lantus SoloSTAR
Sources: Sanofi's Brandicourt looks at spinoff of animal health, selling supplement biz
Fierce Pharma
Sun, 09/27/15 - 08:31 pm
Tags:
Olivier Brandicourt, Sanofi, spinoffs, animal health
The Price War for New Cholesterol Drugs Is Heating Up
Motley Fool
Fri, 09/25/15 - 08:48 pm
Tags:
PCSK9 inhibitors, drug pricing, Regeneron, Sanofi, Amgen, Praluent, Repatha
op-selling drugs might be first in line for Medicare price negotiations
Fierce Pharma
Wed, 09/23/15 - 09:50 pm
Tags:
Medicare, drug pricing, Hillary Clinton, GSK, Advair, AstraZeneca, Crestor, Merck, Januvia, Sanofi, Lantus, Celgene, Revlimid
What Drove Sanofi’s Growth in 2Q15?
Yahoo/Market Realist
Mon, 09/21/15 - 10:30 pm
Tags:
Sanofi, earnings
Sanofi, Pfizer Said to Express Interest in Buying Mexico's Rimsa
Bloomberg
Sat, 09/19/15 - 09:13 am
Tags:
Sanofi, Pfizer, Mexico, M&A, Rimsa
How Sanofi Is Building For MannKind's Afrezza
Seeking Alpha
Thu, 09/17/15 - 09:52 am
Tags:
Sanofi, MannKind, diabetes, Afrezza, inhaled insulin
Victoza tops Sanofi's Lyxumia in trial, adding to Novo's GLP-1 arsenal
Fierce Pharma
Wed, 09/16/15 - 06:01 pm
Tags:
Victoza, Lyxumia, Novo Nordisk, Sanofi, diabetes, GLP-1 agonist
The Medicare Gravy Train Into Big Pharma's Pockets Keeps Growing
Seeking Alpha
Mon, 09/14/15 - 10:57 am
Tags:
Medicare, Medicaid, AstraZeneca, Gilead Sciences, Merck, Pfizer, Sanofi
Sanofi Reports Positive Top-Line Results in Second Pivotal LixiLan Phase III Study
Yahoo
Mon, 09/14/15 - 08:46 am
Tags:
Sanofi, LixiLan-L, type 2 diabetes
AZ's high-powered Crestor could gain from payer limits on PCSK9 meds
Fierce Pharma Marketing
Fri, 09/11/15 - 09:55 am
Tags:
AstraZeneca, Crestor, PCSK9 inhibitors, drug pricing, Repatha, Praluent, Amgen, Regeneron, Sanofi
Independent group finds new cholesterol drugs far too costly
Yahoo/Reuters
Wed, 09/9/15 - 10:12 pm
Tags:
drug pricing, PCSK9 inhibitors, Praluent, Repatha, Amgen, Sanofi, Regeneron
MannKind: Failure to Launch
Barron's
Wed, 09/9/15 - 09:57 pm
Tags:
MannKind, Afrezza, diabetes, Sanofi, inhaled insulin
PCSK9 Inhibitor Therapies Face Pricing Pressures
Yahoo/Market Realist
Mon, 09/7/15 - 11:45 am
Tags:
PCSK9 inhibitors, drug pricing, Praluent, Repatha, Amgen, Regeneron, Sanofi
2 major insurers draw lines in the sand for pricey PCSK9 coverage
BioPharma Dive
Wed, 09/2/15 - 12:34 pm
Tags:
PCSK9 inhibitors, insurers, Regeneron, Sanofi, Amgen, Praluent, Repatha
Approval Of Repatha May Give Amgen A $5B Boost
Seeking Alpha
Mon, 08/31/15 - 05:28 pm
Tags:
Repatha, Amgen, PCSK9 inhibitors, Praluent, Sanofi, Regeneron
Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes
Yahoo
Mon, 08/31/15 - 09:43 am
Tags:
Sanofi, diabetes, R&D, Google
Lilly, Boehringer amp up fight against Lantus with U.K. biosim launch
Fierce Pharma
Sat, 08/29/15 - 08:57 am
Tags:
Lantus, Eli Lilly, biosimilars, diabetes, Boehringer Ingelheim, Sanofi
The New Cholesterol Lowering Drugs Epitomize The Drug Pricing Battles
Forbes
Fri, 08/28/15 - 08:19 am
Tags:
drug pricing, Repatha, Praluent, Sanofi, Regeneron, Amgen, PCSK9 inhibitors
Bristol-Myers, Sanofi prevail in Plavix false claims case
BioPharma Dive
Wed, 08/26/15 - 10:59 am
Tags:
Plavix, whistleblower lawsuits, False Claims Act, Sanofi, Bristol-Myers Squibb

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.